BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 23815406)

  • 1. Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.
    Singh N; Haldar S; Tripathi AK; Horback K; Wong J; Sharma D; Beserra A; Suda S; Anbalagan C; Dev S; Mukhopadhyay CK; Singh A
    Antioxid Redox Signal; 2014 Mar; 20(8):1324-63. PubMed ID: 23815406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.
    Singh N; Haldar S; Tripathi AK; McElwee MK; Horback K; Beserra A
    Antioxid Redox Signal; 2014 Jul; 21(3):471-84. PubMed ID: 24512387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Insights into the Role of Ferritin in Iron Homeostasis and Neurodegenerative Diseases.
    Zhang N; Yu X; Xie J; Xu H
    Mol Neurobiol; 2021 Jun; 58(6):2812-2823. PubMed ID: 33507490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron chelation and neuroprotection in neurodegenerative diseases.
    Li X; Jankovic J; Le W
    J Neural Transm (Vienna); 2011 Mar; 118(3):473-7. PubMed ID: 21161300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of iron accumulation in microglia and its implications in neuropathological conditions.
    Rathnasamy G; Ling EA; Kaur C
    CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):785-98. PubMed ID: 24047528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders.
    Mills E; Dong XP; Wang F; Xu H
    Future Med Chem; 2010 Jan; 2(1):51-64. PubMed ID: 20161623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain iron metabolism and its perturbation in neurological diseases.
    Crichton RR; Dexter DT; Ward RJ
    J Neural Transm (Vienna); 2011 Mar; 118(3):301-14. PubMed ID: 20809066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron Metabolism in Aging and Age-Related Diseases.
    Tian Y; Tian Y; Yuan Z; Zeng Y; Wang S; Fan X; Yang D; Yang M
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain Iron Metabolism Dysfunction in Parkinson's Disease.
    Jiang H; Wang J; Rogers J; Xie J
    Mol Neurobiol; 2017 May; 54(4):3078-3101. PubMed ID: 27039308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodegenerative diseases and therapeutic strategies using iron chelators.
    Ward RJ; Dexter DT; Crichton RR
    J Trace Elem Med Biol; 2015; 31():267-73. PubMed ID: 25716300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.
    Bergsland N; Tavazzi E; Schweser F; Jakimovski D; Hagemeier J; Dwyer MG; Zivadinov R
    CNS Drugs; 2019 Nov; 33(11):1073-1086. PubMed ID: 31556017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial iron metabolism and its role in neurodegeneration.
    Horowitz MP; Greenamyre JT
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S551-68. PubMed ID: 20463401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of iron in brain ageing and neurodegenerative disorders.
    Ward RJ; Zucca FA; Duyn JH; Crichton RR; Zecca L
    Lancet Neurol; 2014 Oct; 13(10):1045-60. PubMed ID: 25231526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial iron metabolism and neurodegenerative diseases.
    Cheng R; Dhorajia VV; Kim J; Kim Y
    Neurotoxicology; 2022 Jan; 88():88-101. PubMed ID: 34748789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Iron accumulation and neurodegenerative diseases].
    Yoshida K
    Nihon Rinsho; 2016 Jul; 74(7):1161-7. PubMed ID: 27455807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron: a new target for pharmacological intervention in neurodegenerative diseases.
    Whitnall M; Richardson DR
    Semin Pediatr Neurol; 2006 Sep; 13(3):186-97. PubMed ID: 17101458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepcidin and its therapeutic potential in neurodegenerative disorders.
    Qian ZM; Ke Y
    Med Res Rev; 2020 Mar; 40(2):633-653. PubMed ID: 31471929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overdosing on iron: Elevated iron and degenerative brain disorders.
    D'Mello SR; Kindy MC
    Exp Biol Med (Maywood); 2020 Oct; 245(16):1444-1473. PubMed ID: 32878460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential application of iron chelators for the treatment of neurodegenerative diseases.
    Hider RC; Roy S; Ma YM; Le Kong X; Preston J
    Metallomics; 2011 Mar; 3(3):239-49. PubMed ID: 21344071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostics and Treatments of Iron-Related CNS Diseases.
    Xiong H; Tuo QZ; Guo YJ; Lei P
    Adv Exp Med Biol; 2019; 1173():179-194. PubMed ID: 31456211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.